DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Clinical Value of Sequential Gefitinib With Pemetrexed/Platinum for Advanced NSCLC

Phase 2

Completed

Conditions: NSCLC

Interventions: Drug: Pemetrexed/Platinum
Drug: Sequential Gefitinib With Pemetrexed/Platinum

First Posted Date: 2013-01-16

Last Posted Date: 2016-02-23

Lead Sponsor: Fudan University

Target Recruit Count: 117

Registration Number: NCT01769066

Locations: 🇨🇳
Cancer hospital Fudan University, Shanghai, Shanghai, China

Preconceptional Thyroid Screening and Childhood Nerocognitive Function

Not Applicable

Conditions: Hypothyroidism

Interventions: Procedure: levothyroxine

First Posted Date: 2012-12-07

Last Posted Date: 2012-12-11

Lead Sponsor: Fudan University

Target Recruit Count: 600

Registration Number: NCT01744743

Locations: 🇨🇳
Obstetrics and Gynecology Hospital, Fudan University, Shanghai, Shanghai, China

wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients

Phase 2

Conditions: Colorectal Cancer

Interventions: Drug: FOLFIRI regimen
Drug: wXELIRI regimen

First Posted Date: 2012-11-29

Last Posted Date: 2012-11-29

Lead Sponsor: Fudan University

Target Recruit Count: 100

Registration Number: NCT01736904

Locations: 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China

Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy

Phase 3

Completed

Conditions: Pancreatic Neoplasms
Biliary Tract Neoplasms
Duodenal Neoplasms
Pancreatitis, Chronic

Interventions: Procedure: pancreaticojejunostomy

First Posted Date: 2012-11-22

Last Posted Date: 2014-12-04

Lead Sponsor: Fudan University

Target Recruit Count: 308

Registration Number: NCT01731821

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase

Phase 2

Conditions: Carcinoma, Hepatocellular

Interventions: Drug: Huachansu
Other: TACE

First Posted Date: 2012-10-29

Last Posted Date: 2015-12-18

Lead Sponsor: Fudan University

Target Recruit Count: 120

Registration Number: NCT01715532

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: Zoladex

First Posted Date: 2012-10-24

Last Posted Date: 2017-08-25

Lead Sponsor: Fudan University

Target Recruit Count: 216

Registration Number: NCT01712893

Locations: 🇨🇳
FUSCC, Shanghai, Shanghai, China

Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy

Phase 3

Conditions: Gastric Tumor

Interventions: Procedure: Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction

First Posted Date: 2012-10-02

Last Posted Date: 2012-10-16

Lead Sponsor: Fudan University

Target Recruit Count: 140

Registration Number: NCT01697943

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction

Phase 3

Conditions: Adenocarcinoma of Esophagogastric Junction.

Interventions: Other: Total Gastrectomy or Proximal Gastrectomy

First Posted Date: 2012-10-02

Last Posted Date: 2012-10-02

Lead Sponsor: Fudan University

Target Recruit Count: 140

Registration Number: NCT01697917

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

The Optimal Width of Gastric Conduit for Minimally Invasive Esophagectomy: Wide or Narrow?

Not Applicable

Conditions: Anastomotic Leakage

Interventions: Procedure: Narrowed Gastric Conduit
Procedure: Widened Gastric Conduit

First Posted Date: 2012-10-01

Last Posted Date: 2013-02-11

Lead Sponsor: Fudan University

Target Recruit Count: 200

Registration Number: NCT01696682

Locations: 🇨🇳
Division of Thoracic Surgery, Zhongshan Hospital of Fudan University, Shanghai, China

Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC)

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Endostar
Drug: Vinorelbine
Drug: Cisplatin
Radiation: Radiotherapy

First Posted Date: 2012-09-19

Last Posted Date: 2012-09-19

Lead Sponsor: Fudan University

Target Recruit Count: 15

Registration Number: NCT01687439

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy